A. Chachoua
Oncology · 2004–2018
A researcher in the Science corpus: 4 papers; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Oncology — 40 citations into it
- Immunology — 37 citations into it
Whom A. Chachoua trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts A. Chachoua overall
Papers from A. Chachoua's perspective
Ordered by how strongly the researchers A. Chachoua trusts endorse each paper. Same corpus, a different order for every researcher.
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma (New England Journal of Medicine)
- The blockade of immune checkpoints in cancer immunotherapy (Nature Reviews. Cancer)
- CTLA4 blockade and GM-CSF combination immunotherapy alters the intratumor balance of effector and regulatory T cells. (Journal of Clinical Investigation)
- Combining radiotherapy and cancer immunotherapy: a paradigm shift. (Journal of the National Cancer Institute)
- The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. (Genome Research)
- STAR: ultrafast universal RNA-seq aligner (Bioinform.)
- Ipilimumab plus dacarbazine for previously untreated metastatic melanoma. (New England Journal of Medicine)
- Immunologic Correlates of the Abscopal Effect in a Patient with Melanoma (New England Journal of Medicine)
- Fractionated but Not Single-Dose Radiotherapy Induces an Immune-Mediated Abscopal Effect when Combined with Anti–CTLA-4 Antibody (Clinical Cancer Research)
- Immune-mediated inhibition of metastases after treatment with local radiation and CTLA-4 blockade in a mouse model of breast cancer. (Clinical Cancer Research)
Their papers
- Radiotherapy induces responses of lung cancer to CTLA-4 blockade (2018) — 797 citations
- Local radiotherapy and granulocyte-macrophage colony-stimulating factor to generate abscopal responses in patients with metastatic solid tumours: a proof-of-principle trial. (2015) — 613 citations
- An Abscopal Response to Radiation and Ipilimumab in a Patient with Metastatic Non-Small Cell Lung Cancer (2013) — 638 citations
- Determinants of tumor response and survival with erlotinib in patients with non--small-cell lung cancer. (2004) — 1,103 citations